Left Ventricular Assist Device Program (LVAD)
Long-term treatment for heart failure
An LVAD (Left Ventricular Assist Device) is a mechanical pump that assists people suffering from severe heart failure. Traditionally, it has been used as a "bridge to transplant," helping heart failure patients survive while they wait for a donor heart.
In recent years, however, doctors wondered if an LVAD might be a long-term option for patients who for one reason or another were unable to receive a transplant. This theory was tested in a rigorous study with a number of heart failure patients who had little hope of a meaningful life -- and the LVAD gave them back a high level of function. In fact, most recipients of LVAD Destination Therapy are able to return to activities they had given up years earlier.
Founded in early 2012, the Maimonides LVAD Program is led by a team of cardiac surgeons, cardiologists and ventricular assist device coordinators, who work together to offer the latest advances in heart failure management.
The Program utilizes the HeartMate II LVAD, specially designed to function as a long-term treatment for heart failure. Patients supported with this device have lived for many years after implantation. They live at home and can carry out most, if not all, of their favorite activities. The LVAD Destination Therapy Program at Maimonides is committed to treating patients with advanced heart failure, and restoring them to active and rewarding lives.
Fully accredited by the Joint Commission, the advanced certification earned by the Maimonides LVAD Destination Therapy team recognizes their dedication and expertise. On a daily basis, the team provides outstanding patient-centered care, while aligning with the Joint Commission’s high performance standards for safe, high quality treatment.